Abstract
Gestational diabetes (GD) is a complication of pregnancy with an incidence of up to 16%, characterized by alteration in carbohydrate metabolism. It is a condition that favors greater risk of developing complications such as congenital malformations, stillbirth, preeclampsia, fetal macrosomia, polyhydramnios, greater index of cesareans, and hemorrhagic complications that it brings. Its etiology is multifactorial, including genetic determinants such as ethnicity; lifestyle, where sedentary lifestyle plays the most important role; easy access to high-caloric foods; and the socioeconomic level, where the lower strata have the highest risk. Diagnosis is easy to perform from the identification of women of reproductive age with risk factors and from the first prenatal visit, by measuring blood glucose. General measures such as lifestyle and diet modification of the pregnant patient are the beginning of treatment. In the case of not reaching control of glucose levels, oral hypoglycemic drug and insulin are the basis of treatment with the object of maximum reduction of complications for both mother and neonate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liat S, Cabrero L, Hod M, Yogev Y. Obesity in obstetrics. Best Pract Res Clin Obstet and Gynaecol. 2015;29:79–90.
Aviram A, Hod M, Yogev Y. Maternal obesity: implications for pregnancy outcome and long-term risks—a link to maternal nutrition. Int J Gynecol Obstet. 2011;115(Suppl 1):S6–S10.
Albrecht SS, Barquera S, Popkin BM. Exploring secular changes in the association between BMI and waist circumference in Mexican-Origin and White women: a comparison of Mexico and the United States. Am J of Hum Biol. 2014;26:627–34.
ACOG. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol. 2013;122(2 Pt 1):406–16.
McCance DR. Diabetes in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29:685–99.
Lawrence JM. Women with diabetes in pregnancy: different perceptions and expectations. Best Pract Res Clin Obstet Gynaecol. 2011;25:15–24.
Crume TL, Ogden L, West NA, et al. Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: The Exploring Perinatal Outcomes among Children (EPOCH) Study. Diabetologia. 2011;54:87–92.
Hadar E, Ashwal E, Hod M. The preconceptional period as an opportunity for prediction and prevention of non-communicable disease. Best Pract Res Clin Obstet Gynaecol. 2015;29:54–62.
American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In standards of medical care in diabetes 2016. Diabetes Care. 2016;39(Suppl. 1):S13–22.
Sacks DA, Metzger BE. Classification of diabetes in pregnancy. Time to reassess the alphabet. Obstet Gynecol. 2013;121(2):345–8.
The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
Ogunyemi DA, Fong A, Rad S, Fong S, Kjos SL. Attitudes and practices of health care providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28(8):976–86.
Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23. https://doi.org/10.1186/1471-2393-12-23.
McIntyre HD, Metzger BE, Coustan DR, et al. Counterpoint: establishing consensus in the diagnosis of GDM following the HAPO study. Curr Diab Rep. 2014;14:497.
American Diabetes Association. Management of diabetes in pregnancy. Sec. 12. In standards of medical care in diabetes. Diabetes Care. 2016;39(Suppl 1):S94–8.
Buchanan TA. Intermediary metabolism durin pregnancy: implication for diabtes mellitus. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Quest Library. pp. 1237–50.
Buchanan TA. Effects of maternal diabetes mellitus on intrauterine development. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Qeust ebrary. pp. 1251–64.
Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34:205–11.
Guía de Práctica Clínica. Diagnóstico y Tratamiento de la Diabetes en el Embarazo. México: Secretaria de Salud; 2009.
Berggren EK, Boggess KA. Oral agents for the management of gestational diabetes. Clinical Obstet GynecolLippincott Williams and Wilkins. 2013;56(4):827–36.
Spaulonci CP, Bernardes LS, Trindade TC, et al. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol. 2013;209:34. e1–7.
Zhao LP, Sheng XY, Zhou S, Yang T, Ma LY, Zhou Y, Cui YM. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol. 2015;80(5):1224–34.
Singh AK, Singh R. Metformin in gestational diabetes: an emerging contender. Indian J Endocrinol Metab. 2015;19(2):236–44.
Korkmazer E, Solak N, Tokgöz VY. Gestational diabetes: screening, management, timing of delivery. Curr Obstet Gynecol Rep. 2015;4:132–8.
Benhalima K, Devlieger R, Van Assche A. Screening and management of gestational diabetes. Best Pract Res Clin Obstet Gynaecol. 2015;29:339–49.
Garrison EA, Jagasia S. Inpatient management of women with gestational and pregestational diabetes in pregnancy. Curr Diab Rep. 2014;14:457.
Theodoraki A, Baldeweg SE. Symposium on diabetes. Gestational diabetes mellitus. Br J Hosp Med. 2008;69(10):562–7.
Gunderson EP. Breastfeeding after gestational diabetes pregnancy. Diabetes Care ProQuest. 2007;30(S2):S161–8.
Trout KK, Averbuch T, Barowski M. Promoting breastfeeding among obese women and women with gestational diabetes mellitus. Curr Diab Rep. 2011;11(7):7–12.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Glossary
- ACOG
-
The American College of Obstetricians and Gynecologists.
- ADA
-
The American Diabetes Association.
- BMI
-
Is the result of dividing the weight of a person in kilograms by the square of his height in meters.
- Congenital malformations
-
are anatomic alterations that occur in the intrauterine stage and may be alterations in organs, extremities or systems, due to environmental, genetic factors, deficiencies in nutrient capture, or consumption of noxious substances.
- ENSANUT 2012
-
National Health and Nutrition Survey 2012 (Mexico).
- FDA
-
The Food and Drug Administration.
- Fetal macrosomia
-
Traditionally, fetal macrosomia has been defined as arbitrary weight at birth, such as 4000, 4100, 4500, or 4536 grams. It is currently defined as a fetus that is large for gestational age (> 90 percentile).
- GD
-
Gestational diabetes, which is defined as alteration in carbohydrate metabolism diagnosed for the first time in the second or third trimester of gestation.
- HAPO Study
-
Hyperglycemia and Adverse Pregnancy Outcomes study.
- IADPSG
-
The International Association of Diabetes and Pregnancy Study Groups.
- Insulin
-
From the Latin “isla.” It is a polypeptide hormone formed by 51 amino acids, produced and secreted by the beta cells of the Islets of Langerhans of the pancreas. Discovered by Frederick Grant Banting, Charles Best, James Collip, and J.J.R. Macleod of the University of Toronto, Canada in 1921.
- NIH
-
National Institutes of Health.
- Obesity
-
Obesity and overweight are defined as abnormal or excessive accumulation of fat that may prejudice health. A simple way to measure obesity is the body mass index (BMI), which is the weight of a person divided by height in meters squared. A person with BMI equal or above 30 is considered obese and with a BMI equal or greater than 25 is considered overweight.
- Oral hypoglycemic drugs
-
Antidiabetic drugs which are classified as sulfonylureas, biguanides, alpha-glucosidase inhibitors, meglitinides (repaglinide, nateglinide) and thiazolidinediones.
- Perinatal mortality
-
is the fetus and newborn risk of dying as a consequence of the reproductive process.
- Premature birth
-
According to WHO, birth that occurs after week 20 and before 37 complete weeks.
- T1D
-
Type 1 diabetes, which is secondary to the destruction of the beta cells of the pancrease, and in general leads to absolute insulin deficiency.
- T2D
-
Type 2 diabetes, which is due to a progressive loss of insulin secretion.
- WHO
-
World Health Organization.
- Women of reproductive age
-
Women between 15 and 44 years.
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
García-Argueta, M.I., González-Espejel, M. (2019). Pregnancy: Pregestational and Gestational Management. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-030-11815-0_61
Download citation
DOI: https://doi.org/10.1007/978-3-030-11815-0_61
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11814-3
Online ISBN: 978-3-030-11815-0
eBook Packages: MedicineMedicine (R0)